Time to Antiretroviral Treatment Initiation and Factors associated to Same Day Initiation in the West Region of Cameroon

Download Article

DOI: 10.21522/TIJPH.2013.10.02.Art004

Authors : Fabrice Djouma Nembot, Frankline Sevidzem Wirsiy, Edouard Katayi Tshimwanga, Claude Ngwayu Nkfusai, Mboh Khan Eveline, Ismaila Esa, Walters Kum, Agbornkwai Nyenty Agbor, Jerome Ateudjieu


Same-day Antiretroviral Treatment (ART) initiation after a positive HIV test result is vital for faster viral suppression. This study assessed the time to ART initiation and factors associated to SDAI in the West region of Cameroon. This was a cross-sectional retrospective study. The data was extracted from registers and patients’ medical records and analysed. The mean age of the 3053 participants was 36.9 (SD: 13.3), and 64.0% were female. A total of 2346 (76.8%) participants had initiated ART the same day of the diagnosis. Female gender (OR= 1.2; 95%CI:1.1-1.5), Tier 3 HF (OR= 1.3; 95%CI: 1-1.7), semi-urban facility’s location (OR= 1.4; 95%CI: 1.1-1.7), periods of test January-March 2020 (OR= 2; 95%CI: 1.6-2.6), April- June 2020 (OR= 1.7; 95%CI: 1.3-2.2), and July- September 2020 (OR= 3.4; 95%CI: 2.5-4.6), index case testing entry point (OR= 1.6; 95%CI: 1.2-2.1), active occupational situation (OR= 1.3; 95%CI: 1-1.7), and good general status (OR= 1.3; 95%CI: 1.1-1.6) were independently associated to same day initiation. In addition to WHO stage 2 (OR= 0.6; 95%), tuberculosis (OR= 0.2; 95%CI: 0.1-0.5), inpatient (OR= 0.2; 95%CI: 0.1-0.4) and emergency entry point (OR= 0.1; 95%CI: 0-0.2) were inversely associated to SDI. The ART initiation was timely for most clients in the West region of Cameroon, in alignment with the WHO recommendations. However, this was not the case among symptomatic, critically ill, and tuberculosis clients. This underscores the need for ongoing support, counselling, and continuous readiness assessment, as well as a strong linkage system for clients with delayed ART initiation.

Keywords: Antiretroviral Treatment (ART), Cameroon, Factors, Same-day initiation, West Region.


[1] WHO. WHO publishes new clinical and service delivery recommendations for HIV prevention, treatment, and care [Internet]. 2021 [cited 2021 Nov 16]. Available from: https://www.who.int/news/item/17-03-2021-who-publishes-new-clinical-recommendations-on-hiv-prevention-infant-diagnosis-antiretroviral-therapy-initiation-and-monitoring.

[2] PEPFAR CSH gov D last updated: Global HIV/AIDS Overview [Internet]. HIV.gov. 2021 [cited 2021 Nov 16]. Available from: https://www.hiv.gov/federal-response/pepfar-global-aids/global-hiv-aids-overview.

[3] Moges NA, Adesina OA, Okunlola MA, Berhane Y. Same-day antiretroviral treatment (ART) initiation and associated factors among HIV positive people in Northwest Ethiopia: baseline characteristics of a prospective cohort. Arch Public Health. 2020 Dec;78(1):1–13.

[4] Hayes R, Sabapathy K, Fidler S. Universal Testing and Treatment as an HIV Prevention Strategy: Research Questions and Methods. Curr HIV Res. 2011 Sep;9(6):429–45.

[5] Bayisa L, Abera T, Mulisa D, Mosisa G, Mosisa A, Tolosa T, et al. Time to Antiretroviral Therapy Initiation and Its Predictors Among Newly Diagnosed HIV-Positive People in Nekemte Town, Western Ethiopia: Claim of Universal Test and Treat HIVAIDS - Res Palliat Care. 2021 Oct 9;13:959–72.

[6] Marsh K, Eaton JW, Mahy M, Sabin K, Autenrieth CS, Wanyeki I, et al. Global, regional and country-level 90–90–90 estimates for 2018: assessing progress towards the 2020 target. AIDS Lond Engl. 2019 Dec 15;33(Suppl 3):S213–26.

[7] Bain LE, Nkoke C, Noubiap JJN. UNAIDS 90–90–90 targets to end the AIDS epidemic by 2020 are not realistic: comment on “Can the UNAIDS 90–90–90 target be achieved? A systematic analysis of national HIV treatment cascades.” BMJ Glob Health. 2017 Mar 7;2(2):e000227.

[8] Antela A, Rivero A, Llibre JM, Moreno S, the RET Group. Redefining therapeutic success in HIV patients: an expert view. J Antimicrob Chemother. 2021 Oct 1;76(10):2501–18.

[9] The INSIGHT START Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015 Aug 27;373(9):795–807.

[10] Ingabire PM, Semitala F, Kamya MR, Nakanjako D. Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90 of HIV-Infected Individuals. AIDS Res Treat. 2019 Apr 1;2019:e1832152.

[11] Ahmed S, Autrey J, Katz IT, Fox MP, Rosen S, Onoya D, et al. Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low- and middle-income countries. Soc Sci Med. 2018 Sep 1;213:72–84.

[12] Maughan-Brown B, Harrison A, Galárraga O, Kuo C, Smith P, Bekker L-G, et al. Factors affecting linkage to HIV care and ART initiation following referral for ART by a mobile health clinic in South Africa: evidence from a multimethod study. J Behav Med. 2019 Oct;42(5):883–97.

[13] Moges NA, Adesina OA, Okunlola MA, Berhane Y. Barriers and Facilitators of Same-Day Antiretroviral Therapy Initiation Among People Newly Diagnosed with HIV in Ethiopia: Qualitative Study Using the Transtheoretical Model of Behavioral Change. J Multidiscip Healthc. 2020 Dec 2;13:1801–15.

[14] MacPherson P, Lalloo DG, Webb EL, Maheswaran H, Choko AT, Makombe SD, et al. Effect of Optional Home Initiation of HIV Care Following HIV Self-testing on Antiretroviral Therapy Initiation Among Adults in Malawi: A Randomized Clinical Trial. JAMA. 2014 Jul 23;312(4):372–9.

[15] Scott NA, Maskew M, Fong RM, Olson IE, Brennan AT, Fox MP, et al. Patient Perspectives of Quality of the Same-Day Antiretroviral Therapy Initiation Process in Gauteng Province, South Africa: Qualitative Dominant Mixed-Methods Analysis of the SLATE II Trial. Patient - Patient-Centered Outcomes Res. 2021 Mar 1;14(2):175–86.

[16] Mbeya Munkhondya TE, Smyth RM, Lavender T. Facilitators and barriers to retention in care under universal antiretroviral therapy (Option B+) for the Prevention of Mother to Child Transmission of HIV (PMTCT): A narrative review. Int J Afr Nurs Sci. 2021 Jan 1;15:100372.

[17] Lilian RR, Rees K, McIntyre JA, Struthers HE, Peters RPH. Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: Analysis of routine data. PLOS ONE. 2020 Jan 14;15(1):e0227572.

[18] Nhassengo P, Cataldo F, Magaço A, Hoffman RM, Nerua L, Saide M, et al. Barriers and facilitators to the uptake of Test and Treat in Mozambique: A qualitative study on patient and provider perceptions. PLoS ONE. 2018 Dec 26;13(12):e0205919.

[19] National Data Reporting software. Population Statistics. 2021.

[20] Boyd M, Boffito M, Castagna A, Estrada V. Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps. HIV Med. 2019;20(S1):3–11.

[21] Pry J, Chipungu J, Smith HJ, Bolton Moore C, Mutale J, Duran-Frigola M, et al. Patient-reported reasons for declining same-day antiretroviral therapy initiation in routine HIV care settings in Lusaka, Zambia: results from a mixed-effects regression analysis. J Int AIDS Soc. 2020 Jul;23(7):e25560.

[22] Rufu A, Chitimbire VTS, Nzou C, Timire C, Owiti P, Harries AD, et al. Implementation of the “Test and Treat” policy for newly diagnosed people living with HIV in Zimbabwe in 2017. Public Health Action. 2018 Sep 21;8(3):145–50.

[23] Factors Influencing Rapid Antiretroviral Therapy Initiation at Four eThekwini Clinics, KwaZulu-Natal, South Africa | SpringerLink [Internet]. [cited 2021 Dec 15]. Available from: https://link.springer.com/article/10.1007/s10461-021-03530-3.

[24] Ahmed I, Demissie M, Worku A, Gugsa S, Berhane Y. Effectiveness of same-day antiretroviral therapy initiation in retention outcomes among people living with human immunodeficiency virus in Ethiopia: empirical evidence. BMC Public Health. 2020 Nov 26;20(1):1802.

[25] Katbi M, Adegboye A, Adedoyin A, Yunusa F, Kayode G, Bello M, et al. Effect of clients Strategic Index Case Testing on community-based detection of HIV infections (STRICT study). Int J Infect D is IJID Off Publ Int Soc Infect Dis. 2018 Sep;74:54–60.

[26] Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, et al. Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial. PLoS Med. 2016 May;13(5):e1002015.